Will the Phase 2 trial "Randomized Controlled Trial of Berberine in Combination With Doxycycline in the Treatment of Chronic Endometritis" reach primary completion on or before Nov 30, 2026?

Resolves Yes if ClinicalTrials.gov record NCT07180563 (The Fourth Affiliated Hospital of Zhejiang University School of Medicine) shows an actual primary completion date on or before Nov 30, 2026. Registered date at generation: Nov 30, 2026.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Nov 30, 2026, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.